News
Fintel reports that on March 11, 2025, LifeSci Capital initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Outperform recommendation. As of March 4, 2025, the average one-year price ...
Fintel reports that on March 14, 2025, Cantor Fitzgerald initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Overweight recommendation. As of March 4, 2025, the average one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback